Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Jul;216(1):17–21. doi: 10.1097/00000658-199207000-00003

Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer.

B L Smith 1, M Bertagnolli 1, B B Klein 1, S Batter 1, M Chang 1, L M Douville 1, T J Eberlein 1
PMCID: PMC1242541  PMID: 1321595

Abstract

Ninety-five women who underwent blind contralateral breast biopsy during surgical treatment of a known breast cancer primary were studied prospectively. All biopsies were performed between 1981 and 1989. Patients with palpable or mammographic abnormalities prompting the contralateral biopsy were excluded so that the study sample included only truly blind contralateral biopsies. Only two infiltrating carcinomas were found, resulting in a positive biopsy rate of 2.1% for invasive disease. Three additional biopsies showed only lobular carcinoma in situ, a finding that usually does not alter clinical management. One patient with a negative contralateral biopsy developed invasive carcinoma in that breast within 2 years of the biopsy. The authors were unable to identify any subgroup of patients at increased risk of a positive contralateral biopsy. These results suggest that blind biopsy of the contralateral breast performed at the time of the initial treatment of breast carcinoma is not an efficient method of cancer detection. Alternative management strategies are discussed.

Full text

PDF
17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpers C. E., Wellings S. R. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol. 1985 Aug;16(8):796–807. doi: 10.1016/s0046-8177(85)80251-3. [DOI] [PubMed] [Google Scholar]
  2. Andersen J. A. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer. 1977 Jun;39(6):2597–2602. doi: 10.1002/1097-0142(197706)39:6<2597::aid-cncr2820390644>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  3. Andersen L. I., Muchardt O. Simultaneous bilateral cancer of the brease--evaluation of the use of a contralateral biopsy. Acta Chir Scand. 1980;146(6):407–409. [PubMed] [Google Scholar]
  4. Baker L. H. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin. 1982 Jul-Aug;32(4):194–225. doi: 10.3322/canjclin.32.4.194. [DOI] [PubMed] [Google Scholar]
  5. Baker R. R., Kuhajda F. P. The clinical management of a normal contralateral breast in patients with lobular breast cancer. Ann Surg. 1989 Oct;210(4):444–448. doi: 10.1097/00000658-198910000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collette H. J., Day N. E., Rombach J. J., de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet. 1984 Jun 2;1(8388):1224–1226. doi: 10.1016/s0140-6736(84)91704-5. [DOI] [PubMed] [Google Scholar]
  7. Dall'Olmo C. A., Ponka J. L., Horn R. C., Jr, Riu R. Lobular carcinoma of the breast in situ. Are we too radical in its treatment? Arch Surg. 1975 May;110(5):537–542. doi: 10.1001/archsurg.1975.01360110083015. [DOI] [PubMed] [Google Scholar]
  8. Fenig J., Arlen M., Livingston S. F., Levowitz B. S. The potential for carcinoma existing synchronously on a microscopic level within the second breast. Surg Gynecol Obstet. 1975 Sep;141(3):394–396. [PubMed] [Google Scholar]
  9. Fisher E. R., Fisher B., Sass R., Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer. 1984 Dec 15;54(12):3002–3011. doi: 10.1002/1097-0142(19841215)54:12<3002::aid-cncr2820541231>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  10. Gülay H., Hamaloğlu E., Bulut O., Göksel H. A. Bilateral breast carcinoma: 28 years' experience. World J Surg. 1990 Jul-Aug;14(4):529–534. doi: 10.1007/BF01658684. [DOI] [PubMed] [Google Scholar]
  11. King R. E., Terz J. J., Lawrence W., Jr Experience with opposite breast biopsy in patients with operable breast cancer. Cancer. 1976 Jan;37(1):43–45. doi: 10.1002/1097-0142(197601)37:1<43::aid-cncr2820370107>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  12. Leis H. P., Jr Bilateral breast cancer. Surg Clin North Am. 1978 Aug;58(4):833–841. doi: 10.1016/s0039-6109(16)41595-1. [DOI] [PubMed] [Google Scholar]
  13. Martin J. K., Jr, van Heerden J. A., Gaffey T. A. Synchronous and metachronous carcinoma of the breast. Surgery. 1982 Jan;91(1):12–16. [PubMed] [Google Scholar]
  14. Palli D., Del Turco M. R., Buiatti E., Carli S., Ciatto S., Toscani L., Maltoni G. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer. 1986 Oct 15;38(4):501–504. doi: 10.1002/ijc.2910380408. [DOI] [PubMed] [Google Scholar]
  15. Pressman P. I. Selective biopsy of the opposite breast. Cancer. 1986 Feb 1;57(3):577–580. doi: 10.1002/1097-0142(19860201)57:3<577::aid-cncr2820570330>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  16. Rosen P. P., Groshen S., Kinne D. W., Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989 Nov;106(5):904–910. [PubMed] [Google Scholar]
  17. Rosen P. P., Kosloff C., Lieberman P. H., Adair F., Braun D. W., Jr Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978 Sep;2(3):225–251. doi: 10.1097/00000478-197809000-00001. [DOI] [PubMed] [Google Scholar]
  18. Rosen P. P., Senie R. T., Farr G. H., Schottenfeld D., Ashikari R. Epidemiology of breast carcinoma: Age, menstrual status, and exogenous hormone usage in patients with lobular carcinoma in situ. Surgery. 1979 Feb;85(2):219–224. [PubMed] [Google Scholar]
  19. Shapiro S., Venet W., Strax P., Venet L., Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982 Aug;69(2):349–355. [PubMed] [Google Scholar]
  20. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  21. Urban J. A., Papachristou D., Taylor J. Bilateral breast cancer: biopsy of the opposite breast. Cancer. 1977 Oct;40(4 Suppl):1968–1973. doi: 10.1002/1097-0142(197710)40:4+<1968::aid-cncr2820400832>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  22. Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Sturmans F., Day N. E. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet. 1984 Jun 2;1(8388):1222–1224. doi: 10.1016/s0140-6736(84)91703-3. [DOI] [PubMed] [Google Scholar]
  23. Verweij J., Stoter G., Dodion P., Farinean M. Rapid alkalinisation for flavone acetic acid administration: a potentially hazardous procedure. Lancet. 1988 Feb 20;1(8582):411–412. doi: 10.1016/s0140-6736(88)91200-7. [DOI] [PubMed] [Google Scholar]
  24. Wanebo H. J., Senofsky G. M., Fechner R. E., Kaiser D., Lynn S., Paradies J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg. 1985 Jun;201(6):667–677. doi: 10.1097/00000658-198506000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wheeler J. E., Enterline H. T., Roseman J. M., Tomasulo J. P., McIlvaine C. H., Fitts W. T., Jr, Kirshenbaum J. Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974 Sep;34(3):554–563. doi: 10.1002/1097-0142(197409)34:3<554::aid-cncr2820340313>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES